Delivery Order SPE2DB22D3010-SPE2DB25FP2PY
- Not listed
- The Defense Logistics Agency awarded a $12,322.75 delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, with an ultimate completion date of October 24, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor based in Conshohocken, Pennsylvania. The pharmaceutical product will be delivered to the same location, supporting federal medical supply requirements. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 MG, with a ceiling value of $13,338.54 under a firm fixed-price contract type. The delivery order was competitively awarded without set-aside provisions and has an ultimate completion date of August 4, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,371.12 to supply Ondansetron HCL 4 mg tablets in a quantity of 30 units. This delivery order, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a firm fixed-price transaction with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency awarded a delivery order valued at $2,030.04 to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Ondansetron HCL 4 mg tablets (500-count units). This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ondansetron HCl 4 mg tablets in quantities of 30, with a ceiling value of $23,438.54. This is a firm fixed price delivery order with no set-aside designation, completed through open competition. The order is scheduled for ultimate completion by September 2, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a $5,629.86 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply) on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, which is also the headquarters location of the prime contractor. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Ondansetron HCl 4 mg tablets (500 count) with a contract value of $8,155.72. This is a firm fixed-price delivery order under a competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is one of the federal government's primary pharmaceutical distributors and serves as a critical vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a $3,128.51 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ondansetron HCL 4 mg tablets (500 count). The contract is not set-aside and utilizes firm fixed price pricing, with an ultimate completion date of August 20, 2025. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026,...
- The Defense Logistics Agency (DLA) awarded a $11,073.06 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ondansetron HCl 4 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 10, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $212,889.17 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets in quantities of 500 units. This firm fixed price, competitively awarded delivery order is set to be completed by September 30, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, indicating the vendor competed against other qualified...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP2PYDelivery Order
The Defense Logistics Agency awarded a $12,773.08 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of 500 tablets of Ondansetron HCL 4 mg, with completion scheduled for June 3, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a routine pharmaceutical procurement from the government's primary pharmaceutical distributor. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle extending through December 2026. As the prime contractor for this comprehensive contract vehicle, AmerisourceBergen supplies a broad range of pharmaceutical products and medical supplies to support military and federal healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. The competitively awarded IDC demonstrates the vendor's established capability to meet federal procurement requirements and reflects its critical role in supporting military medical supply chains across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 6/2/25 |